Skip to main content
Signal8
Launch Terminal

Parabilis Medicines, Inc. (PBLS)

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc.

NASDAQ:PBLSHealthcare
-9.21%$24.44
AH Close$24.79+1.43%vs close
Mkt Cap$3.02B
Float101.16M
O/S123.53M
Inst Own80.1%
SI8.2%
Dilution
Parabilis Medicines, Inc. logoNASDAQ:PBLS$24.44-9.21%
FormDescription
8-K
7.01
8-K
5.02
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
8-K
5.02,7.01,9.01
13G
Beneficial Ownership Report
10-Q
Quarterly Report
8-K
2.02,7.01,9.01
13G
Beneficial Ownership Report
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
13D
Beneficial Ownership Report (Active)
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership

1-25 of 62